Skip to main content
Premium Trial:

Request an Annual Quote

There Goes Our Patent on Air

David Koepsell at IPWatchdog argues that genes should not be patentable. In this post, and in his new book, Who Owns You, he says that "gene patents violate the patent law because what they claim as patentable is a part of nature, and thus neither new nor non-obvious" and that awarding patents on "non-new discoveries" does not encourage innovation but rather stifles it. Koepsell goes on to add that he views genes as "common" or something that cannot be owned. "Unmodified genes simply cannot be owned, nor should they be," he says.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.